FDA Drug Application (022157) for XYZAL by UCB INC

Back to FDA Applications sponsored by UCB INC

Application Number022157
Product Number001
FormSOLUTION;ORAL
Dosage2.5MG/5ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AA Products in conventional dosage forms not presenting bioequivalence problems
Reference Drug
Drug NameXYZAL
Active IngredientLEVOCETIRIZINE DIHYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient LEVOCETIRIZINE DIHYDROCHLORIDE2


Back to FDA Applications sponsored by UCB INC